ANAC Webinar

05/13/2026 02:00 PM ET

Summary

Protocols and lessons learned in integrating long-acting buprenorphine and antiretrovirals in HIV primary care

Description

Despite availability of effective medications for opioid use disorder (MOUD) like buprenorphine, only 17% of 4.8 million people with OUD received treatment. Long-acting injectable buprenorphine (LAIB) is a promising strategy to improve MOUD access. LAIB has shown better short-term adherence, lower overdose risk, and improved initiation and retention, especially for fentanyl users, compared to oral forms.

Parallel to this, people living with HIV with opioid use disorder have lower rates of retention in care, adherence to antiretroviral therapy and HIV viral load suppression. Nurses in HIV and opioid use disorder care have increasingly improved access and retention to treatment, but integration of long-acting injectable buprenorphine in HIV primary care settings is limited.

In this webinar, we will present implementation of long-acting injectables for buprenorphine and antiretroviral therapy in a HIV primary care clinic, lessons learned and implications for nurse-driven practice to retain patients living with HIV who use opioids in care.

Faculty:

Omeid Heidari, PhD, MPH, ANP-C: University of Washington School of Nursing, Department of Child, Family, and Population Health Nursing

Jehan Budak, MD: University of Washington Associate Professor, Department of Medicine, Division of Allergy & Infectious Diseases, HIV Pathway Director, UW Internal Medicine Residency, Assistant Medical Director, Madison Clinic, Harborview Medical Center

Learning Outcomes

Upon completion of this activity, participants will be able to:

  • Describe the clinical benefits of long-acting injectable buprenorphine (LAIB) compared to oral MOUD, including its impact on treatment initiation, adherence and retention among people with opioid use disorder.
  • Identify at least two nurse-driven strategies to integrate long-acting injectable therapies for buprenorphine and antiretroviral treatment in HIV primary care settings to improve patient retention and outcomes.

Register

After registering, you will receive a confirmation email containing information about joining the webinar. ANAC will provide 1 contact hour of NCPD for the successful completion of this event.

The Association of Nurses in AIDS Care (ANAC) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

 

Neon CRM by Neon One
company_logo.png
Facebook Linkedin Twitter